Literature DB >> 26849811

Magnetic resonance-guided laser interstitial thermal therapy: report of a series of pediatric brain tumors.

Zulma Tovar-Spinoza1, Hoon Choi1.   

Abstract

OBJECTIVE Magnetic resonance-guided laser interstitial thermal therapy (MRgLITT) is a novel, minimally invasive treatment that has multiple advantages in pediatric use and broad applicability for different types of lesions. Here, the authors report the preliminary results of the first series of pediatric brain tumors treated with MRgLITT at Golisano Children's Hospital in Syracuse, New York. METHODS Pediatric brain tumors treated with MRgLITT between February 2012 and August 2014 at Golisano Children's Hospital were evaluated retrospectively. Medical records, radiological findings, surgical data, complications, and results of tumor volumetric analyses were reviewed. The Visualase thermal laser system (Medtronic) was used in all MRgLITT procedures. RESULTS This series included 11 patients with 12 tumors (pilocytic astrocytoma, ependymoma, medulloblastoma, choroid plexus xanthogranuloma, subependymal giant cell astrocytoma, and ganglioglioma). A single laser and multiple overlapping ablations were used for all procedures. The mean laser dose was 10.23 W, and the mean total ablation time was 68.95 seconds. The mean initial target volume was 6.79 cm(3), and the mean immediate post-ablation volume was 7.86 cm(3). The mean hospital stay was 3.25 days, and the mean follow-up time was 24.5 months. Tumor volume decreased in the first 3 months after surgery (n = 11; p = 0.007) and continued to decrease by the 4- to 6-month followup (n = 11; mean volume 2.61 cm(3); p = 0.009). Two patients experienced post-ablation complications: transient right leg weakness in one patient, and transient hemiparesis, akinetic mutism, and eye movement disorder in the other. CONCLUSIONS Magnetic resonance-guided laser interstitial thermal therapy is an effective first- or second-line treatment for select pediatric brain tumors. Larger multiinstitutional clinical trials are necessary to evaluate its use for different types of lesions to further standardize practices.

Entities:  

Keywords:  MRgLITT = MR-guided laser interstitial thermal therapy; NF1 = neurofibromatosis Type 1; SEGA = subependymal giant cell astrocytoma; ablation; brain tumor; laser; laser interstitial thermal therapy; minimally invasive surgery; oncology; pediatric

Mesh:

Year:  2016        PMID: 26849811     DOI: 10.3171/2015.11.PEDS15242

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  11 in total

1.  Seizure freedom from recurrent insular low-grade glioma following laser interstitial thermal therapy.

Authors:  T P Easwaran; A Lion; A O Vortmeyer; K Kingery; McDonald Bc; J S Raskin
Journal:  Childs Nerv Syst       Date:  2020-01-11       Impact factor: 1.475

Review 2.  Recent technological advances in pediatric brain tumor surgery.

Authors:  Bassel Zebian; Francesco Vergani; José Pedro Lavrador; Soumya Mukherjee; William John Kitchen; Vita Stagno; Christos Chamilos; Benedetta Pettorini; Conor Mallucci
Journal:  CNS Oncol       Date:  2016-12-21

3.  Thermal Therapy Approaches for Treatment of Brain Tumors in Animals and Humans.

Authors:  A L Bredlau; M A McCrackin; Anjan Motamarry; Kris Helke; Chao Chen; Ann-Marie Broome; Dieter Haemmerich
Journal:  Crit Rev Biomed Eng       Date:  2016

4.  MRI-guided laser interstitial thermal therapy for deep-seated gliomas in children with neurofibromatosis type 1: report of two cases.

Authors:  Kevin A Cross; Afshin Salehi; Mohamed S Abdelbaki; David H Gutmann; David D Limbrick
Journal:  Childs Nerv Syst       Date:  2022-09-15       Impact factor: 1.532

5.  MRI-guided laser interstitial thermal therapy for the treatment of low-grade gliomas in children: a case-series review, description of the current technologies and perspectives.

Authors:  Zulma Tovar-Spinoza; Hoon Choi
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 6.  Hyperthermia treatment advances for brain tumors.

Authors:  Georgios P Skandalakis; Daniel R Rivera; Caroline D Rizea; Alexandros Bouras; Joe Gerald Jesu Raj; Dominique Bozec; Constantinos G Hadjipanayis
Journal:  Int J Hyperthermia       Date:  2020-07       Impact factor: 3.914

Review 7.  How Intraoperative Tools and Techniques Have Changed the Approach to Brain Tumor Surgery.

Authors:  Parastou Fatemi; Michael Zhang; Kai J Miller; Pierre Robe; Gordon Li
Journal:  Curr Oncol Rep       Date:  2018-09-26       Impact factor: 5.075

8.  Neuronavigator-guided ventriculoscopic approach for symptomatic xanthogranuloma of the choroid plexus in the lateral ventricle.

Authors:  Chengrui Yan; Shan Zhu; Haitao Sun; Wan-Ting Lee Jenn; Xiaoying Zhang; Zongsheng Xu; Xiangyi Kong; Xiaolin Chen
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

9.  Awake Laser Ablation for Patients With Tumors in Eloquent Brain Areas: Operative Technique and Case Series.

Authors:  Sabastian Hajtovic; Alon Mogilner; John Ard; Jose E Gautreaux; Hannah Britton; Girish Fatterpekar; Matthew G Young; Dimitris G Placantonakis
Journal:  Cureus       Date:  2020-12-20

10.  Magnetic resonance-guided stereotactic laser ablation therapy for the treatment of pediatric brain tumors: a multiinstitutional retrospective study.

Authors:  Elsa V Arocho-Quinones; Sean M Lew; Michael H Handler; Zulma Tovar-Spinoza; Matthew Smyth; Robert Bollo; David Donahue; M Scott Perry; Michael L Levy; David Gonda; Francesco T Mangano; Phillip B Storm; Angela V Price; Daniel E Couture; Chima Oluigbo; Ann-Christine Duhaime; Gene H Barnett; Carrie R Muh; Michael D Sather; Aria Fallah; Anthony C Wang; Sanjiv Bhatia; Kadam Patel; Sergey Tarima; Sarah Graber; Sean Huckins; Daniel M Hafez; Kavelin Rumalla; Laurie Bailey; Sabrina Shandley; Ashton Roach; Erin Alexander; Wendy Jenkins; Deki Tsering; George Price; Antonio Meola; Wendi Evanoff; Eric M Thompson; Nicholas Brandmeir
Journal:  J Neurosurg Pediatr       Date:  2020-03-27       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.